Reaction

Cerebral Hypoperfusion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 453 reports · 21 co-occurring drugs

As of the last recalculation, Cerebral Hypoperfusion appears in 453 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is RASAGILINE MESYLATE (PRR 330.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Rasagiline Mesylate68330.1332.1
Bisacodyl Suppositories66274.2275.6
Biscodyl66271.7273.1
Bisacodyl66252.0253.2
Instalax Polyethylene Glycol 335043175.8176.4
Polyethylene Glycol 40043172.0172.6
Rabeprazole67162.9163.4
Rabeprazole Sodium4584.184.2
Pramipexole2166.066.1
Amitriptyline Hydrochloride1746.246.3
Metformin Hydrochloride Tablets4943.943.9
Metformin Hydrochloride Extended-Release Tablets4943.943.9
Metformin Hydrochloride Tablet4943.943.9
Metformin Hydrochloride4942.542.6
Rocuronium Bromide623.723.7
Memantine620.420.4
Memantine Hydrochloride620.420.4
Oseltamivir317.417.4
Methadone Hydrochloride417.117.1
Iohexol316.716.7
Sevoflurane316.716.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.